Hunan Dajiaweikang Pharmaceutical Industry News

Hunan Dajiaweikang Pharmaceutical Industry: Announcement on Progress of External Guarantee

Jul 9 06:12 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement Regarding Change of Business Scope of Wholly-Owned Subsidiary and Completion of Industrial and Commercial Change Registration.

Jul 9 06:12 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement regarding the progress of repurchasing company shares.

Jul 1 04:42 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement on Progress of External Guarantee

Jun 28 04:07 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement Regarding Change of Business Scope of Wholly-Owned Subsidiary and Completion of Industrial and Commercial Change Registration.

Jun 24 03:42 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement regarding the expiration of the specific shareholder's shareholding plan.

Jun 17 08:32 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement Regarding the Company's First Share Repurchase

Jun 5 05:14 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement regarding the progress of repurchasing company shares.

Jun 4 03:48 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement on the progress of external guarantees

May 30 06:08 ET

Hunan Dajiaweikang Pharmaceutical Industry: 2023 Annual Equity Distribution Implementation Notice

May 21 07:36 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement on the adjustment of the maximum price and quantity of shares to be repurchased after the implementation of equity distribution in 2023

May 21 07:36 ET

Hunan Dajiaweikang Pharmaceutical Industry: Legal Opinion of Hunan Qiyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.

May 14 06:00 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 14 06:00 ET

Hunan Dajiaweikang Pharmaceutical Industry: Announcement on the progress of the repurchase of company shares

May 7 03:42 ET

Hunan Dajiaweikang Pharmaceutical Industry: 301126 Dajia Weikang Investor Relations Management Information 20240429

Apr 29 05:46 ET

Dajia Weikang: Announcement on holding the 2023 Online Results Briefing

Apr 25 04:29 ET

Hunan Dajiaweikang Pharmaceutical Industry: Special audit instructions on the 2023 non-operating capital occupation and other related capital transactions of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.

Apr 24 23:43 ET

Hunan Dajiaweikang Pharmaceutical Industry: Verification report and special report on the annual storage and use of funds raised in 2023 of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.

Apr 24 23:43 ET

Dajia Weikang: Report of Guojin Securities Co., Ltd. on the 2023 continuous supervision and training of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.

Apr 22 12:00 ET

Dajia Weikang: Announcement on changes in accounting policies

Apr 22 12:00 ET